Skip to content

Author

A. Guillon

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Preprint Sep 2026

PK/PD-integrated Bayesian platform design for phase II dose regimen optimization

A Bayesian phase II adaptive platform design for regimen optimization that integrates pharmacokinetic/pharmacodynamic (PK/PD) modelling into toxicity, efficacy, regimen selection and adaptation decisions is developed.

A. Vuorinen, A. Guillon, E. Comets et al. · 0 citations
Aug 2026

Outcomes of patients with Waldenström macroglobulinemia in ICU: a retrospective multicentric study.

BACKGROUND Waldenström macroglobulinemia (WM) is a rare lymphoplasmacytic lymphoma, that can lead to life-threatening complications requiring intensive care unit (ICU) admission. This study aimed to describe the clinical characteristics, WM-specific complications, and outcomes of WM patients admitted to the ICU. METH...

Camille Barraud, Aalliayah Velletrie, Stephanie Harel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.